ID
19264
Description
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00086593
Link
https://clinicaltrials.gov/show/NCT00086593
Keywords
Versions (3)
- 12/16/16 12/16/16 -
- 4/19/18 4/19/18 - Sarah Riepenhausen
- 9/20/21 9/20/21 -
Uploaded on
December 16, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00086593
Eligibility Schizophrenia NCT00086593
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Positive and negative syndrome scale Increase Percent | Positive and negative syndrome scale Decrease Percentage
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0451383
- UMLS CUI [1,2]
- C0442805
- UMLS CUI [1,3]
- C0439165
- UMLS CUI [2,1]
- C0451383
- UMLS CUI [2,2]
- C0547047
- UMLS CUI [2,3]
- C0439165
Description
Axis I diagnosis predominant | Schizophrenia
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0270287
- UMLS CUI [1,2]
- C1542147
- UMLS CUI [2]
- C0036341
Description
Disease Clinical Significance Interferes with Clinical Trial | Disease Unstable Interferes with Clinical Trial | Therapeutic procedure Clinical Significance Interferes with Clinical Trial | Therapeutic procedure Unstable Interferes with Clinical Trial
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C2826293
- UMLS CUI [1,3]
- C0521102
- UMLS CUI [1,4]
- C0008976
- UMLS CUI [2,1]
- C0012634
- UMLS CUI [2,2]
- C0443343
- UMLS CUI [2,3]
- C0521102
- UMLS CUI [2,4]
- C0008976
- UMLS CUI [3,1]
- C0087111
- UMLS CUI [3,2]
- C2826293
- UMLS CUI [3,3]
- C0521102
- UMLS CUI [3,4]
- C0008976
- UMLS CUI [4,1]
- C0087111
- UMLS CUI [4,2]
- C0443343
- UMLS CUI [4,3]
- C0521102
- UMLS CUI [4,4]
- C0008976
Description
Autistic Disorder | Pervasive Development Disorder | Organic brain disorder | Dementia | Cerebrovascular accident | Epilepsy | Seizures Requirement Therapeutic procedure | Febrile Convulsions | Craniocerebral Trauma
Data type
boolean
Alias
- UMLS CUI [1]
- C0004352
- UMLS CUI [2]
- C0524528
- UMLS CUI [3]
- C4062280
- UMLS CUI [4]
- C0497327
- UMLS CUI [5]
- C0038454
- UMLS CUI [6]
- C0014544
- UMLS CUI [7,1]
- C0036572
- UMLS CUI [7,2]
- C1514873
- UMLS CUI [7,3]
- C0087111
- UMLS CUI [8]
- C0009952
- UMLS CUI [9]
- C0018674
Description
Psychotropic Drugs | Central Nervous System Agents Primary
Data type
boolean
Alias
- UMLS CUI [1]
- C0033978
- UMLS CUI [2,1]
- C0007680
- UMLS CUI [2,2]
- C0205225
Description
Antidepressive Agents | Mood Stabilizer
Data type
boolean
Alias
- UMLS CUI [1]
- C0003289
- UMLS CUI [2]
- C2917435
Similar models
Eligibility Schizophrenia NCT00086593
- StudyEvent: Eligibility
C1514241 (UMLS CUI [1,2])
C0205322 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C0023226 (UMLS CUI [2,2])
C0442805 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0451383 (UMLS CUI [2,1])
C0547047 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C1542147 (UMLS CUI [1,2])
C0036341 (UMLS CUI [2])
C2826293 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0087111 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C0008976 (UMLS CUI [3,4])
C0087111 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0521102 (UMLS CUI [4,3])
C0008976 (UMLS CUI [4,4])
C0524528 (UMLS CUI [2])
C4062280 (UMLS CUI [3])
C0497327 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0014544 (UMLS CUI [6])
C0036572 (UMLS CUI [7,1])
C1514873 (UMLS CUI [7,2])
C0087111 (UMLS CUI [7,3])
C0009952 (UMLS CUI [8])
C0018674 (UMLS CUI [9])
C0007680 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C2917435 (UMLS CUI [2])